Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Martin Avenue Pharmacy, Inc.

Martin Avenue Pharmacy, Inc. Recalls

All product recalls associated with Martin Avenue Pharmacy, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

118

Past Year

0

Class I (Serious)

0

Most Recent

Aug 2014

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 118 recalls

Lidocaine Injectable (Martin Avenue Pharmacy) – sterility concerns (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Acetylcysteine 10% Ophthalmic Solution (Martin Avenue Pharmacy) – sterility concerns (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Previous

12 3...6

Page 1 of 6Next

PGE 2 Injectable 100 mcg/mL (Martin Avenue) – sterility risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Dihydroergotamine Mesylate Injection (Martin Avenue Pharmacy) – Sterility Concerns (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Testosterone Cypionate Injectable (Martin Avenue) – sterility concern (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Hydromorphone HCl Injectable (Martin Avenue) – sterility concern (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Chlorhexidine 0.02% Ophthalmic Solution (Martin Avenue Pharmacy) – Sterility Risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Polyhexamethylene Biguanide 0.02% Opthalmic Solution (Martin Avenue) – sterility risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Tri-mix T106 (Martin Avenue Pharmacy) – sterility concerns (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Polyhexamethylene Biguanide 2% Solution (Martin Avenue) – sterility risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Tri-mix T25 Injectable (Martin Avenue) – sterility risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Cyclosporine Corn Oil (Martin Avenue Pharmacy) – sterility concerns (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Bupivacaine 0.25% Injectable (Martin Avenue Pharmacy) – Sterility Risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Prednisolone Acetate 50 mg/mL Injectable (Martin Avenue) – sterility risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Methylcobalamin 1mg/mL Injectable (Martin Avenue Pharmacy) – Sterility Risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Phenylephrine Injectable (Martin Avenue) – sterility concern (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Rescue Solution with Triamcinolone (Martin Avenue Pharmacy) – Sterility Risk (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Hydroxyzine Hydrochloride Injectable (Martin Avenue) – Sterility Concern (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Opthalmic Ointment Base (Martin Avenue Pharmacy) – Sterility Concern (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.

Lidocaine Injectable (Martin Avenue) – sterility concern (2014)

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Class IIModerate

FDAAug 27, 2014Nationwide• Martin Avenue Pharmacy, Inc.